Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products
Can decentralized additive manufacturing bring customized medicines to targeted patient groups?
Edd Stone of TTP explains how the industry is overcoming the manufacturing challenges associated with cell therapies.
What role can regulators play in overcoming the barriers to the adoption of continuous manufacturing processes?
Creating a patient-centric ecosystem in India.
Why is there a need for innovation in cell line development technology?
How do we reduce the presence of pharmaceuticals in water?
Nominations are now open for The Medicine Maker 2021 Innovation Awards.
How individually coded vials give manufacturers the ability to track vials moving through fill and finish lines.
Is there data demonstrating significant cost benefits from continuous biomanufacturing?
As trials change and adapt, so too must clinical packaging.
Mark Thomas Smith
How do we choose the right bioprocessing technologies for the short and long term?
Lori Muffly believes collaboration and innovation – bolstered during the COVID-19 pandemic – will guide the future of stem cell transplant.
If the industry can figure out 3D printing’s regulatory hurdles, we may be on the cusp of a revolution: the democratization of personalized precision.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.